CLINICAL_TRIALS
trial_result
· 2019-11-25
Clinical Trial Update: A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma [Phase 3]
Summary
Phase 3 trial evaluating Symbicort Turbuhaler used as needed in adults and adolescents with asthma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2019-11-25